403 related articles for article (PubMed ID: 36810108)
1. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
Zhou X; Li C; Chen T; Li W; Wang X; Yang Q
Mol Cancer; 2023 Feb; 22(1):36. PubMed ID: 36810108
[TBL] [Abstract][Full Text] [Related]
2. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J; Huang T; Deng Z; Zou C
Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
[TBL] [Abstract][Full Text] [Related]
3. Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.
Liu W; Liu C; Wang H; Xu L; Zhou J; Li S; Cheng Y; Zhou R; Zhao L
Comput Struct Biotechnol J; 2022; 20():5150-5161. PubMed ID: 36187919
[TBL] [Abstract][Full Text] [Related]
4. Targeting RNA N
Li W; Hao Y; Zhang X; Xu S; Pang D
Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
[TBL] [Abstract][Full Text] [Related]
5. RNA N
Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy.
Luo P; Li S; Long X
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188873. PubMed ID: 36842764
[TBL] [Abstract][Full Text] [Related]
7. Targeting the RNA m
Li X; Ma S; Deng Y; Yi P; Yu J
Mol Cancer; 2022 Mar; 21(1):76. PubMed ID: 35296338
[TBL] [Abstract][Full Text] [Related]
8. The regulation of N6-methyladenosine modification in PD-L1-induced anti-tumor immunity.
Yu W; Lin J; Yu T; Lou J; Qian C; Xu A; Liu B; Tao H; Jin L
Immunol Cell Biol; 2023 Mar; 101(3):204-215. PubMed ID: 36630591
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Wang D; Zhang Y; Li Q; Zhang A; Xu J; Li Y; Li W; Tang L; Yang F; Meng J
Biomed Pharmacother; 2023 Nov; 167():115477. PubMed ID: 37696088
[TBL] [Abstract][Full Text] [Related]
10. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.
Zhang Z; Liu F; Chen W; Liao Z; Zhang W; Zhang B; Liang H; Chu L; Zhang Z
Exp Hematol Oncol; 2022 May; 11(1):30. PubMed ID: 35590394
[TBL] [Abstract][Full Text] [Related]
11. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
Liang Z; Kidwell RL; Deng H; Xie Q
Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
[TBL] [Abstract][Full Text] [Related]
13. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
Ouyang X; Gong Y
Front Immunol; 2022; 13():912526. PubMed ID: 35720276
[TBL] [Abstract][Full Text] [Related]
14. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
15. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors.
Tong H; Wei H; Smith AO; Huang J
Front Immunol; 2021; 12():802049. PubMed ID: 35069586
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances of RNA m
Ma S; Barr T; Yu J
Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
[TBL] [Abstract][Full Text] [Related]
17. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
18. The potential role of m6A modifications on immune cells and immunotherapy.
Gan L; Zhao Y; Fu Y; Chen Q
Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
[TBL] [Abstract][Full Text] [Related]
19. N
Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
Front Immunol; 2021; 12():697026. PubMed ID: 34526985
[TBL] [Abstract][Full Text] [Related]
20. RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Li H; Hu J; Yu A; Othmane B; Guo T; Liu J; Cheng C; Chen J; Zu X
Front Oncol; 2021; 11():642159. PubMed ID: 33816290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
